
Rezolute RZLT
$ 3.13
1.79%
Quarterly report 2025-Q4
added 02-12-2026
Rezolute P/E Ratio 2011-2026 | RZLT
Annual P/E Ratio Rezolute
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.87 | -3.62 | -1.53 | -0.687 | -0.00147 | -4.89 | -0.619 | -0.71 | -2.24 | -1.69 | -2.95 | -1.78 | -4.7 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.00147 | -7.87 | -2.56 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 4.55 | -0.66 % | $ 10.9 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Compugen Ltd.
CGEN
|
5.55 | $ 2.59 | -5.31 % | $ 242 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-4.91 | $ 0.91 | 3.25 % | $ 6.69 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
14.1 | $ 22.57 | -0.44 % | $ 3.74 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Evogene Ltd.
EVGN
|
-2.18 | $ 0.78 | -0.66 % | $ 27.9 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Fennec Pharmaceuticals
FENC
|
-17.3 | $ 6.33 | -5.52 % | $ 181 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Galapagos NV
GLPG
|
-42.8 | $ 27.94 | -1.69 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
33.2 | $ 26.19 | -2.24 % | $ 16 B | ||
|
Avenue Therapeutics
ATXI
|
-0.0467 | - | -52.27 % | $ 4.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.136 | - | 17.91 % | $ 11.1 M | ||
|
Atreca
BCEL
|
-0.504 | - | -11.76 % | $ 5.79 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 100.7 | -1.33 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M | ||
|
Innoviva
INVA
|
5.98 | $ 23.2 | -2.08 % | $ 1.56 B | ||
|
Innate Pharma S.A.
IPHA
|
-6.87 | $ 1.45 | 3.57 % | $ 235 M | ||
|
Inventiva S.A.
IVA
|
-10.8 | $ 4.93 | -1.5 % | $ 138 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.06 | -0.73 % | $ 434 M | ||
|
Jaguar Health
JAGX
|
-0.0178 | $ 0.23 | -5.44 % | $ 536 K | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 22.63 | -2.86 % | $ 2.88 B | ||
|
KalVista Pharmaceuticals
KALV
|
-7.63 | $ 26.73 | 38.9 % | $ 1.44 B | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.42 | -4.39 % | $ 378 M | ||
|
Kamada Ltd.
KMDA
|
-121 | $ 8.14 | -0.09 % | $ 260 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 2.95 | 1.37 % | $ 4.86 M |